These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists. Karim F; Roerig SC Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811 [TBL] [Abstract][Full Text] [Related]
5. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors. Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859 [TBL] [Abstract][Full Text] [Related]
6. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy. Chabot-Doré AJ; Millecamps M; Stone LS J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246 [TBL] [Abstract][Full Text] [Related]
7. Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice. Fairbanks CA; Posthumus IJ; Kitto KF; Stone LS; Wilcox GL Pain; 2000 Jan; 84(1):13-20. PubMed ID: 10601668 [TBL] [Abstract][Full Text] [Related]
9. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord. Overland AC; Kitto KF; Chabot-Doré AJ; Rothwell PE; Fairbanks CA; Stone LS; Wilcox GL J Neurosci; 2009 Oct; 29(42):13264-73. PubMed ID: 19846714 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. Fairbanks CA; Stone LS; Wilcox GL Pharmacol Ther; 2009 Aug; 123(2):224-38. PubMed ID: 19393691 [TBL] [Abstract][Full Text] [Related]
12. Moxonidine, a mixed alpha(2)-adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia. Stone LS; Fairbanks CA; Wilcox GL Ann N Y Acad Sci; 2003 Dec; 1009():378-85. PubMed ID: 15028616 [TBL] [Abstract][Full Text] [Related]
13. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice. Andurkar SV; Gendler L; Gulati A Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379 [TBL] [Abstract][Full Text] [Related]
14. DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Guo XH; Fairbanks CA; Stone LS; Loh HH Pain; 2003 Jul; 104(1-2):209-17. PubMed ID: 12855331 [TBL] [Abstract][Full Text] [Related]
16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095 [TBL] [Abstract][Full Text] [Related]
17. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457 [TBL] [Abstract][Full Text] [Related]
18. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia. Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166 [TBL] [Abstract][Full Text] [Related]
19. Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathecal N-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat. Roh DH; Seo HS; Yoon SY; Song S; Han HJ; Beitz AJ; Lee JH Anesth Analg; 2010 Feb; 110(2):622-9. PubMed ID: 20007733 [TBL] [Abstract][Full Text] [Related]
20. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Wang XM; Zhang ZJ; Bains R; Mokha SS Pain; 2002 Jul; 98(1-2):27-35. PubMed ID: 12098614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]